Citadel Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.73M | Sell |
246,930
-393,643
| -61% | -$16M | ﹤0.01% | 3444 |
|
|
2025
Q4 | $26M | Buy |
640,573
+585,407
| +1,061% | +$25.5M | ﹤0.01% | 2059 |
|
|
2025
Q3 | $2.59M | Buy |
55,166
+35,056
| +174% | +$1.82M | ﹤0.01% | 5562 |
|
|
2025
Q2 | $1.05M | Buy |
+20,110
| New | +$1.1M | ﹤0.01% | 6980 |
|
|
2025
Q1 | – | Sell |
-28,631
| Closed | -$1.85M | – | 14599 |
|
|
2024
Q4 | $1.96M | Buy |
28,631
+14,534
| +103% | +$1.01M | ﹤0.01% | 5669 |
|
|
2024
Q3 | $1.01M | Sell |
14,097
-224,428
| -94% | -$15.8M | ﹤0.01% | 6842 |
|
|
2024
Q2 | $16.5M | Buy |
238,525
+82,442
| +53% | +$6.01M | ﹤0.01% | 2195 |
|
|
2024
Q1 | $12.5M | Buy |
156,083
+141,413
| +964% | +$12.6M | ﹤0.01% | 2639 |
|
|
2023
Q4 | $1.61M | Sell |
14,670
-20,257
| -58% | -$2.09M | ﹤0.01% | 5767 |
|
|
2023
Q3 | $3.52M | Sell |
34,927
-174,141
| -83% | -$20M | ﹤0.01% | 4210 |
|
|
2023
Q2 | $28.4M | Buy |
209,068
+205,228
| +5,344% | +$25.1M | 0.01% | 1534 |
|
|
2023
Q1 | $399K | Sell |
3,840
-377,562
| -99% | -$36.5M | ﹤0.01% | 8777 |
|
|
2022
Q4 | $33.8M | Buy |
381,402
+241,877
| +173% | +$20.1M | 0.01% | 1444 |
|
|
2022
Q3 | $11.2M | Buy |
139,525
+48,350
| +53% | +$4.56M | ﹤0.01% | 2612 |
|
|
2022
Q2 | $8.73M | Sell |
91,175
-76,211
| -46% | -$9.15M | ﹤0.01% | 2868 |
|
|
2022
Q1 | $24.9M | Buy |
167,386
+147,605
| +746% | +$20.6M | 0.01% | 1740 |
|
|
2021
Q4 | $2.8M | Sell |
19,781
-120,993
| -86% | -$17.1M | ﹤0.01% | 5469 |
|
|
2021
Q3 | $18.4M | Buy |
140,774
+53,831
| +62% | +$7.04M | ﹤0.01% | 2121 |
|
|
2021
Q2 | $11.9M | Sell |
86,943
-193
| -0.2% | -$26.4K | ﹤0.01% | 2808 |
|
|
2021
Q1 | $11.4M | Buy |
87,136
+60,792
| +231% | +$7.32M | ﹤0.01% | 2788 |
|
|
2020
Q4 | $2.95M | Buy |
26,344
+2,723
| +12% | +$258K | ﹤0.01% | 4612 |
|
|
2020
Q3 | $1.86M | Sell |
23,621
-10,719
| -31% | -$874K | ﹤0.01% | 4844 |
|
|
2020
Q2 | $2.47M | Sell |
34,340
-33,135
| -49% | -$2.31M | ﹤0.01% | 4185 |
|
|
2020
Q1 | $3.86M | Buy |
67,475
+16,847
| +33% | +$1.55M | ﹤0.01% | 3085 |
|
|
2019
Q4 | $5.66M | Sell |
50,628
-47,571
| -48% | -$5.07M | ﹤0.01% | 2927 |
|
|
2019
Q3 | $9.44M | Buy |
98,199
+50,925
| +108% | +$4.78M | ﹤0.01% | 2287 |
|
|
2019
Q2 | $4.04M | Sell |
47,274
-174,588
| -79% | -$14.4M | ﹤0.01% | 3408 |
|
|
2019
Q1 | $18.5M | Buy |
221,862
+178,613
| +413% | +$13M | 0.01% | 1412 |
|
|
2018
Q4 | $2.78M | Sell |
43,249
-130,715
| -75% | -$8.94M | ﹤0.01% | 3647 |
|
|
2018
Q3 | $13.8M | Buy |
173,964
+26,949
| +18% | +$2.08M | 0.01% | 1743 |
|
|
2018
Q2 | $10.8M | Buy |
147,015
+143,599
| +4,204% | +$9.77M | 0.01% | 1860 |
|
|
2018
Q1 | $216K | Sell |
3,416
-31,505
| -90% | -$1.88M | ﹤0.01% | 7235 |
|
|
2017
Q4 | $1.78M | Buy |
34,921
+30,333
| +661% | +$1.58M | ﹤0.01% | 3794 |
|
|
2017
Q3 | $241K | Sell |
4,588
-19,816
| -81% | -$995K | ﹤0.01% | 6396 |
|
|
2017
Q2 | $1.24M | Sell |
24,404
-49,723
| -67% | -$2.46M | ﹤0.01% | 3789 |
|
|
2017
Q1 | $3.29M | Buy |
74,127
+53,556
| +260% | +$2.3M | ﹤0.01% | 2478 |
|
|
2016
Q4 | $909K | Sell |
20,571
-89,033
| -81% | -$3.78M | ﹤0.01% | 3987 |
|
|
2016
Q3 | $4.39M | Buy |
109,604
+103,643
| +1,739% | +$4.4M | ﹤0.01% | 2110 |
|
|
2016
Q2 | $285K | Buy |
+5,961
| New | +$252K | ﹤0.01% | 5290 |
|
|
2016
Q1 | – | Sell |
-13,716
| Closed | -$604K | – | 6906 |
|
|
2015
Q4 | $604K | Sell |
13,716
-10,510
| -43% | -$456K | ﹤0.01% | 4209 |
|
|
2015
Q3 | $1.16M | Buy |
24,226
+22,555
| +1,350% | +$1.24M | ﹤0.01% | 3627 |
|
|
2015
Q2 | $97K | Sell |
1,671
-3,744
| -69% | -$202K | ﹤0.01% | 7101 |
|
|
2015
Q1 | $273K | Buy |
5,415
+3,554
| +191% | +$174K | ﹤0.01% | 5785 |
|
|
2014
Q4 | $84K | Buy |
1,861
+658
| +55% | +$27.6K | ﹤0.01% | 6786 |
|
|
2014
Q3 | $44K | Sell |
1,203
-97,798
| -99% | -$3.88M | ﹤0.01% | 6973 |
|
|
2014
Q2 | $4.37M | Buy |
99,001
+44,924
| +83% | +$2.04M | 0.01% | 1954 |
|
|
2014
Q1 | $2.35M | Buy |
54,077
+41,763
| +339% | +$1.86M | ﹤0.01% | 2485 |
|
|
2013
Q4 | $523K | Sell |
12,314
-10,330
| -46% | -$393K | ﹤0.01% | 3976 |
|
|
2013
Q3 | $770K | Buy |
+22,644
| New | +$739K | ﹤0.01% | 3365 |
|
Other funds holding CNMD
VPM
VCM
CB
Citadel Advisors's CNMD Position: Q1 2026 in Review
Citadel Advisors reduced its CONMED (CNMD) stake by 61% in Q1 2026, selling an estimated $16M and leaving 246,930 shares worth $8.73M. The position accounts for ﹤0.01% of the portfolio, ranked #3444.
Citadel Advisors first reported a position in CNMD in Q3 2013 and has held it in 49 quarters since. The position peaked at $33.8M in Q4 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Citadel Advisors held 246,930 shares of CONMED worth $8.73M as of Q1 2026.
- Citadel Advisors sold 393,643 CONMED shares in Q1 2026, an estimated $16M.
- CONMED made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3444 holding.
- Citadel Advisors first reported a position in CONMED in Q3 2013 and has held it in 49 quarters since.
- Citadel Advisors's CONMED position peaked at $33.8M in Q4 2022.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.